| Question |
Answer |
| Acetaminopen/Codeine | Class: Narcotics/NSAID Combo... Indication: Pain, cough |
| Albuterol | Class: Beta-2 adrenergic agonist Indication: bronchospasms |
| Alendronate | Class: Osteoporosis/Calcium Metabolism MofA: inhibits osteoclast activity (bisphosphate) Indication: Osteoporosis, Pagets disease |
| Allopurinol | Class: Nephrolithiasis ; Gout MofA: inhibits xanthine oxidase, dec Uric acid Indication: Gout prophylaxis, hyperuricemia |
| Amlodipine | Class: Calcium Channel Blocker, dihydropyridines Indication: HTN, CAD |
| Amlodipine+Benazepril | Class: Calcium Channel Blocker+ACE inhib Indication: HTN |
| Amphetamine+Dextroamphetamine | Class: Stimulants MofA: stimulates CNS, blocks reuptake of NE & Dopa Indication: ADHD |
| Atomoxetine | Class: psychotropic agent/antidepressant MofA: inhib pre-synaptic NE transport Indication: ADHD |
| Atorvastin | Class: Cholesterol Lowering Mofa: inhibs HmgCoA "statin" Indication: Hyperlipidermia/Hypercholesterolemia |
| Bupropion | Class: Antidepressants, other MofA: unknown, but known blocks NE/Dopa reuptake Indication: Depression, Seasonal Affective Disorder, ADHD |
| Rabeprazole | Class: Antacid Mofa: PPI Indication: GERD, PUP, Zollinger-Elison Syndrome |
| Esomeprazole | Class: Antacid MofA: PPI Indication: GERD, PUP, Zollinger-Elison Syndrome |
| Lansoprazole | Class: Antacid MofA: PPI Indication: GERD, PUP, Zollinger-Elison |
| Pantoprazole | Class: Antacid MofA: PPI Indication: GERD, PUP, Zollinger-Elison |
| Polyethylene Glycol | Class: Osmotic Laxative MofA: H2O retention in stool Indicatio: Constipation |
| Pioglitazone | Class: Diabetes Med MofA: Increases Insulin Sensitivity |
| Rosiglitazone | Class: Diabetes Med MofA: Increases Insulin Sensitivity |
| Insulin Lispro | Class: Diabetes Med MofA: stimulates peripheral glucose uptake, inhibs hepatic glucose prod, inhibits lipolysis & proteolysis Indication: DM and hyperglycemia |
| Insulin glargine | Class: Diabetes Med MofA: stimulates peripheral glucose uptake, inhibs hepatic glucose prod, inhibits lipolysis & proteolysis Indication: DM and hyperglycemia |
| Metformin | Class: Diabetes meds Mofa: dec hepatic glucose prod & and intestinal absorption |
| Levothyroxine | Class: Thyroid med MofA: analogue to thyroxine (multiple effects) Indication: Hypothyroid |
| Latanoprost | Class: Glaucoma med MofA: Prostaglandin F-alpha-2 analogue...increases vitreous outflow Indication: IOP |
| Warfarin | Class: Anti-coag MofA: Inhibs Vit K coag Factor syn (II, VII, IX, X, Protein and S) Indication: DVT |
| Clopidrogel | Class: Anticoag MofA: inhibits ADP binding to platelet receptor Indication: Thrombotic event risk |
| Moxifloxacin | Class: Antimicrobial MofA: Fluoroquinolone (inhibs DNA gyrase) |
| Levofloxacin | Class: Antimicrobial MofA: Fluoroquinolone (inhibs DNA gyrase) |
| Cefdinir | Class: Antimicrobial MofA: 3rd gen Cephalo...Beta lactamIndication: broad spectrum |
| Valacyclovir | Class: Antimicrobial MofA: inhibs viral DNA synthesis Indication: HSV infection |
| Methylphenidate | Class: PsychotropicMofA: stimulates CNS, blocks reuptake of NE & Dopa Indication: ADHD |
| Zolpidem | Class: Sedatives MofA: GABA-Benzodiazepine recep interaction Indication: Insomnia |
| Eszopiclone | Class: Sedatives MofA: GABA-Benzodiazepine recep interaction Indication: Insomnia |
| Donepezil | Class: Dementia Drug MofA: inhibits Acytelcholinesterase Indication mild/severe Azheimers |
| Memantine | Class Dementia Drug MofA: NMDA receptor Antag...slow Ca++ influx Indication: Alzheimers, mod/severe dementia |
| Ropinirole | Class: Parkinsons drug MOFA: Dopamine agonist Indication: Parkinsons, Restless Leg |
| Duloxetine | Class: Antidepressant MofA: SSRI Indication: Major Depressive Disorder |
| Venlafaxine | Class: Antidepressant MofA: SSRI, NE, Dopa reuptake inhibitor Indication: Major Depressive Disorder, Panic Disorder, Generalized Anxiety Disorder, Social Anxiety disorder |
| Escitalopram | Class: Antidepressant MofA: SSRI Indication: Major Depressive Disorder, Generalized Anxiety |
| Trazadone | Class: Antidepressant MofA: SSRI Indication: Major depression, Anxiety, Insomnia |
| Escitalopram | Class: Antidepressant MofA: SSRI Indication: Major depression, Anxiety, Insomnia |
| Lorazepam | Class: Anticonvulsant/Sedative MofA: Binds Benzodiazepine receptors to enhance GABA Indication: insomnia, nause vomiting (chemo related), status epilepticus |
| Pregabalin | Class: analgesic MofA: Gaba analogue, inc levels of Gaba Indication: Anxiety, Neuralgia |
| Olanzapine | Class: Antipsychotic MofA: antagonizes D2 receptor, 5HT2 receptor and others Indication: Mania, Schizophrenia |
| Risperidone | Class: Antipsychotic MofA: antagonizes D2 receptor, 5HT2 receptor and others Indication: Mania, Schizophrenia |
| Quetiapine | Class: Antipsychotic MofA: antagonizes D2 receptor, 5HT2 receptor and others Indication: Mania, Schizophrenia |
| Topiramate | Class: Anticonvulsant/Migraine med MofA: unknown Indication: seizures, migraines |
| Clonazepam | Class: Anticonvulsant/Sedative MofA: Binds Benzodiazepine receptors to enhance GABA Indication: insomnia, nause vomiting (chemo related), status epilepticus |
| Divalproex Sodium | Class: Anticonvulsant/Migraine med MofA: unknown/ Na Channel blocker Indication: Seizures, migraines |
| Lamotrigine | Class: Anticonvulsant/Migraine med MofA: unknown/ Na Channel blocker Indication: absence/partial/tonic-clonic seizures |
| Vernicline | Class: Smoking cessation MofA: antagonizes AcH nicotinic receptors Indication: smoking |
| Celecoxib | Class: Pain Reliever/NSAID MofA: Cox-2 inhib Inidication: Osteoarthritis, RA, Dysmenorrhea |
| Oxycodone+acetominophen | Class: Pain reliever MofA: Opiod receptor binding + NSAID Indication: Mod-severe pain |
| Hydrocodone + Acetaminophen | Class: Pain reliever MofA: Opiod receptor binding + NSAID Indication: Mod-severe pain |
| Lidocaine Patch | Class: analgesic/anasthetic MofA: inhibs Na channel, stabilizes neuronal member Indication: post-herpetic neuralgia |
| Naproxen | lass: Pain Reliever/NSAID MofA: Cox inhib Inidication: Osteoarthritis, RA, Dysmenorrhea |
| Sumatriptan | Class: SSRI/Migraine Med MofA: Activates vascular 5HT1 receptors Indication: Migraines , cluster HAs |
| Metaxalone | Class: muscle relaxant MofA: centrally acting Indication: muscle spasm |
| Cyclobenzaprine | Class: muscle relaxant MofA: centrally acting Indication: muscle spasm |
| Furosemide | Class: Hypertensive med MofA: inhibs loop of henle and PCT resorption Indication: HTN, Pulmonary Edema, Hypercalcemia |
| HCTZ | Class: Hypertensive MofA: diuretic, inhibs NA and CL resorption at DCT Indication: edema, HTN |
| Rampiril | Class: Hypertensive MofA: ACE inhibitor Indicaton: HTN, CHF, Cardiac event risk |
| Losartan | Class: Hypertensive MofA: A2RB Indication: HTN, neuropathy |
| Irbesartan | Class: Hypertensive MofA: A2RB Indication: HTN, neuropathy |
| Olmesartan + HCTZ | Class: Hypertensive MofA: A2RB+ DCT diuretic Indication: HTN, neuropathy |
| Valsartan + HCTZ | Class: Hypertensive MofA: A2RB+ DCT diuretic Indication: HTN, neuropathy |
| Triamterene + HCTZ | Class: Hypertensive MofA: inhibs Aldosterone-induced sodium resorption+ inhibs Na+Cl resorption @ DCT Indication: HTN |
| Amlodipine | Class: Hypertensive MofA: Calcium Channel Blocker Indication: HTN, CAD |
| Amlodipine + Benazepril | Class: Hypertensive MofA: Calcium Channel Blocker+ ACE inhibitor Indication: HTN, CAD |
| Carvedilol | Class: Beta blocker MofA: antagonizes Beta1 and Beta2 receps (and Alpha1) Indication: CHF, HTN, Liver dysfunction, Post MI |
| Metroprolol | Class: Beta Blocker MofA: antagonizes Beta 1 and Beta 2 Indication: CHF, HTN, Angina |
| Digoxin | Class: Antiarhythmic MofA: inhibs Na/K pump Indication: CHF, Vtach |
| Rosuvastatin | Class: Cholesterol lowering MofA: inhibs HMG-CoA reductase Indication: Hyperlipidemia, Hypercholesterolemia |
| Atorvastatin | Class: Cholesterol lowering MofA: inhibs HMG-CoA reductase Indication: Hyperlipidemia, Hypercholesterolemia |
| Niacin | Class: Cholesterol Lowering MofA: participates in respiration Ox-Red, dec LDL and VDL Indication: hypercholesteralemia, dyslipidemia |
| Fenofibrate | Class: Cholesterol lowering MofA: inhibs triglyceride synthesis Indication: dyslipidemia |
| Ezetimibe + Simvastatin | Class: Cholesterol Lowering MofA: Inhibs chol uptake at brush border + inhibs HMG CoA reductase Indicatin: familial hypercholesteralemia |
| Ezetimibe | Class: Cholesterol lowering MofA: inhibs chol uptake at brush border |
| Potassium | Indication: hypokalemia |
| Albuterol | Class: Bronchodilator MofA: Beta-2 agonist Indication: bronchospasms |
| Salmeterol + Fluticasone | Class: Bronchodilator MofA: Beta-2 agonist+ Antihistamine Indication: bronchospasms, asthma |
| Ipratropium + Albterol | Class: Bronchodilator MofA: Blocks AcH at receptor+Beta-2 Agonist Indication: bronchospasm |
| Tiotropium | Class: Bronchodilator Mofa: antagonizes M1, M2, M3 AcH receptrors Indication: COPD |
| Motelukast | CLass: Antiinflamm Mofa: binds leukotriene receps Indication: Asthma maintenance, allergic rhinitis |
| Fexofenadine | Class: Allergy med MofA: antihistamine (H1) Indication: allergic rhinitis |
| Fluticasone | Class: allergy med MofA: nasal steroid Indication: allergic/non-allergic rhinitis |
| Triamcinolon | Class: allergy med MofA: nasal steroid Indication: allergic/non-allergic rhinitis |
| Mometasone | Class: allergy med MofA: nasal steroid Indication: allergic/non-allergic rhinitis |
| Olopatadine | Class: Allergy med MofA: antihistamine (H1) Indication: allergic rhinitis |
| Cetirizie | Class: Allergy med MofA: antihistamine (H1) Indication: allergic rhinitis |
| Risendronate | Class: Anti-osteoporosis MofA: Bisphosphonate=inhibs osteoclast Indication: Pagets, osteoporosis |
| Ibandronate | Class: Anti-osteoporosis MofA: Bisphosphonate=inhibs osteoclast Indication: Pagets, osteoporosis |
| Alendronate | Class: Anti-osteoporosis MofA: Bisphosphonate=inhibs osteoclast Indication: Pagets, osteoporosis |
| Raloxifene | Class: Anti-osteoporosis MofA: Estrogen receptor modulator--inhibs bone resorption |
| Etonogestrel+Ethinyl Estradiol | Class: Contraceptives MofA: Suppresses LH and FSH, inhibiting ovulation and altering mucus and endo |
| Ethinyl estradiol+Drospirenone | Class: Contraceptives MofA: Suppresses LH and FSH, inhibiting ovulation and altering mucus and endo |
| Drospirenone+Ethinyl Estradiol | Class: Contraceptives MofA: Suppresses LH and FSH, inhibiting ovulation and altering mucus and endo |
| Conjugated Estrogens | Class: Hormone therapy MofA: binds estrogen receptor, developing and maintaining female chars and reproductive systems Indication: Menopausal sx, vasomotor sx, vulvovaginal atrophy |
| Norgestimate+Ethinyl estradiol | Clas Oral Contraceptive MofA: suppresses HPA decreasing GnRH release |
| Tadafil | Class: Men's health MofA inhibs Phosphodiesterase-->enhancing cGMP Indication: Erectile Dysfunction |
| Sildenafil | Class: Men's health MofA inhibs Phosphodiesterase-->enhancing cGMP Indication: Erectile Dysfunction |
| Tamsulosin | Class: Adrenergic antagonist MofA: binds alpha-1 receptor, relaxing smooth muscle Indication: BPH |
| Tolterodine | Class: Anti-Ach (muscarinic) MofA: binds and blocks peripheral AcH receptors (in bladder) Indication: overactive bladder |
Science Vocab 147928
